| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Damage | 13 | 2014 | 1954 | 1.180 |
Why?
|
| MicroRNAs | 14 | 2015 | 2947 | 0.890 |
Why?
|
| Phosphoprotein Phosphatases | 4 | 2010 | 214 | 0.800 |
Why?
|
| RNA, Long Noncoding | 5 | 2016 | 598 | 0.670 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2011 | 154 | 0.480 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2013 | 1823 | 0.480 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2012 | 507 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 2508 | 0.370 |
Why?
|
| Oncogene Proteins | 1 | 2011 | 354 | 0.340 |
Why?
|
| Cell Cycle Proteins | 4 | 2013 | 2045 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2012 | 3552 | 0.330 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 5 | 2013 | 430 | 0.310 |
Why?
|
| DNA, Complementary | 2 | 2016 | 869 | 0.290 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 5159 | 0.280 |
Why?
|
| Osteosarcoma | 2 | 2010 | 929 | 0.280 |
Why?
|
| Transcription, Genetic | 4 | 2013 | 3154 | 0.270 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 854 | 0.270 |
Why?
|
| Transfection | 6 | 2012 | 2944 | 0.250 |
Why?
|
| Receptors, Somatotropin | 2 | 2003 | 17 | 0.250 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 4821 | 0.250 |
Why?
|
| Protein Phosphatase 2C | 4 | 2010 | 75 | 0.220 |
Why?
|
| DNA Repair | 6 | 2013 | 1872 | 0.220 |
Why?
|
| Turtles | 1 | 2000 | 11 | 0.190 |
Why?
|
| Bone Neoplasms | 2 | 2010 | 2576 | 0.190 |
Why?
|
| Signal Transduction | 9 | 2015 | 11965 | 0.180 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2011 | 316 | 0.160 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 1213 | 0.160 |
Why?
|
| Animals | 19 | 2014 | 59536 | 0.150 |
Why?
|
| Phosphorylation | 5 | 2013 | 4804 | 0.150 |
Why?
|
| Mice | 12 | 2014 | 34495 | 0.130 |
Why?
|
| Polyadenylation | 1 | 2016 | 70 | 0.130 |
Why?
|
| RNA Interference | 4 | 2013 | 1408 | 0.130 |
Why?
|
| Histones | 2 | 2013 | 1466 | 0.120 |
Why?
|
| Breast Neoplasms | 5 | 2013 | 15694 | 0.120 |
Why?
|
| Receptor, EphB2 | 1 | 2013 | 17 | 0.120 |
Why?
|
| Mice, Knockout | 4 | 2012 | 5710 | 0.120 |
Why?
|
| Homeodomain Proteins | 3 | 2013 | 1143 | 0.120 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2013 | 80 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2011 | 1682 | 0.110 |
Why?
|
| Base Sequence | 2 | 2016 | 4917 | 0.110 |
Why?
|
| Protein Phosphatase 1 | 1 | 2012 | 79 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 255 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 159 | 0.110 |
Why?
|
| Receptor, EphA2 | 1 | 2013 | 132 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2013 | 3536 | 0.110 |
Why?
|
| Cell Physiological Phenomena | 1 | 2012 | 24 | 0.110 |
Why?
|
| Exosomes | 1 | 2015 | 253 | 0.110 |
Why?
|
| Chromosomal Instability | 1 | 2013 | 233 | 0.100 |
Why?
|
| Gene Expression | 1 | 2000 | 3570 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 317 | 0.100 |
Why?
|
| E2F1 Transcription Factor | 1 | 2013 | 206 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2011 | 5637 | 0.100 |
Why?
|
| Carcinoma, Medullary | 1 | 2013 | 248 | 0.100 |
Why?
|
| Cell Line, Tumor | 8 | 2014 | 14551 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 237 | 0.100 |
Why?
|
| Hyperalgesia | 1 | 2013 | 238 | 0.100 |
Why?
|
| Monocytes | 1 | 2015 | 788 | 0.100 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2011 | 73 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2013 | 519 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 187 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 2216 | 0.090 |
Why?
|
| Enzyme Induction | 1 | 2010 | 249 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 276 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2013 | 238 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 342 | 0.090 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2011 | 216 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2011 | 294 | 0.090 |
Why?
|
| Neuroblastoma | 1 | 2015 | 686 | 0.090 |
Why?
|
| Apoptosis | 6 | 2013 | 7591 | 0.090 |
Why?
|
| Humans | 25 | 2016 | 261506 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 343 | 0.090 |
Why?
|
| Spleen | 1 | 2011 | 676 | 0.080 |
Why?
|
| Luciferases | 1 | 2009 | 445 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2013 | 2450 | 0.080 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 4638 | 0.080 |
Why?
|
| Genetic Therapy | 2 | 2013 | 1616 | 0.080 |
Why?
|
| Trans-Activators | 2 | 2011 | 1555 | 0.080 |
Why?
|
| Gene Amplification | 1 | 2010 | 731 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2013 | 5395 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2009 | 575 | 0.070 |
Why?
|
| Receptors, Drug | 1 | 2006 | 48 | 0.070 |
Why?
|
| Radiography | 1 | 2011 | 1904 | 0.070 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2006 | 42 | 0.070 |
Why?
|
| Gene Silencing | 3 | 2013 | 837 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 741 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2054 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 1547 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 1217 | 0.070 |
Why?
|
| Potassium Channels | 1 | 2006 | 162 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 1390 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 984 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2010 | 4143 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2010 | 2074 | 0.060 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 10331 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 299 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 4053 | 0.060 |
Why?
|
| Cell Line | 3 | 2013 | 5114 | 0.060 |
Why?
|
| COS Cells | 2 | 2003 | 377 | 0.060 |
Why?
|
| Cricetinae | 2 | 2003 | 706 | 0.060 |
Why?
|
| DNA | 1 | 2011 | 2693 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2013 | 1866 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2010 | 1443 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2013 | 1555 | 0.050 |
Why?
|
| HCT116 Cells | 2 | 2013 | 348 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 2488 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5178 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 4233 | 0.050 |
Why?
|
| Cell Movement | 3 | 2013 | 2466 | 0.050 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2013 | 278 | 0.050 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2011 | 1724 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2015 | 8873 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 6089 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2000 | 682 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 289 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2014 | 1489 | 0.040 |
Why?
|
| Mutation | 3 | 2013 | 15179 | 0.040 |
Why?
|
| Neoplasm Metastasis | 3 | 2013 | 5112 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 844 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2013 | 1869 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 694 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 3578 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 3639 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2013 | 7226 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7789 | 0.030 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2015 | 21 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2015 | 79 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2015 | 85 | 0.030 |
Why?
|
| Carrageenan | 1 | 2013 | 15 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 14289 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 3821 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 2013 | 39 | 0.030 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2013 | 42 | 0.030 |
Why?
|
| RNA Transport | 1 | 2013 | 14 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 5061 | 0.030 |
Why?
|
| Hindlimb | 1 | 2013 | 105 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2013 | 80 | 0.030 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2013 | 31 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 626 | 0.030 |
Why?
|
| Nociceptors | 1 | 2013 | 86 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2013 | 112 | 0.030 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2013 | 27 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2013 | 257 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 260 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2013 | 72 | 0.030 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2013 | 32 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2013 | 144 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 6942 | 0.030 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2013 | 159 | 0.030 |
Why?
|
| Female | 9 | 2014 | 141928 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2013 | 358 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 733 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2013 | 6100 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2013 | 208 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 248 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2013 | 323 | 0.030 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2012 | 13 | 0.030 |
Why?
|
| Pericytes | 1 | 2013 | 96 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2013 | 237 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 2013 | 141 | 0.030 |
Why?
|
| Acetylation | 1 | 2013 | 508 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 509 | 0.030 |
Why?
|
| Karyopherins | 1 | 2013 | 136 | 0.030 |
Why?
|
| Cattle | 1 | 2013 | 783 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2012 | 45 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 550 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2013 | 227 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2012 | 303 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2012 | 186 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 760 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 997 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 2146 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 4549 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2013 | 429 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1165 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 664 | 0.020 |
Why?
|
| RNA Stability | 1 | 2011 | 125 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 644 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 1008 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 476 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2013 | 481 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 519 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 430 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 842 | 0.020 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2010 | 87 | 0.020 |
Why?
|
| Neoplasms | 2 | 2013 | 15193 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 576 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 905 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 307 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2010 | 242 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 810 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 987 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 677 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2013 | 5270 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 1549 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2013 | 554 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Cisplatin | 1 | 2015 | 2432 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 2315 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2013 | 1620 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 575 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2010 | 362 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1070 | 0.020 |
Why?
|
| Congenital Hyperinsulinism | 1 | 2006 | 3 | 0.020 |
Why?
|
| Sulfonylurea Receptors | 1 | 2006 | 22 | 0.020 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2006 | 20 | 0.020 |
Why?
|
| Catecholamines | 1 | 2006 | 101 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 1643 | 0.020 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2006 | 67 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 3438 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 4307 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1987 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2013 | 1664 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 1248 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 2864 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 4844 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 1265 | 0.010 |
Why?
|
| Models, Biological | 1 | 2013 | 3254 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3981 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 6150 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 1439 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 728 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2003 | 241 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2330 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 1487 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 311 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2359 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 1732 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 9244 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 1454 | 0.010 |
Why?
|
| Glucose | 1 | 2006 | 1248 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1537 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 2171 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 3343 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 12926 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 1054 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 2961 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 1362 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 21713 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 8223 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 7222 | 0.010 |
Why?
|
| Male | 2 | 2013 | 123000 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 32848 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 13310 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 11538 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 70117 | 0.000 |
Why?
|
| Adult | 1 | 2013 | 77950 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 86204 | 0.000 |
Why?
|